MA44779A - Compositions de produit pharmaceutique comprenant un marqueur d'événement ingérable - Google Patents

Compositions de produit pharmaceutique comprenant un marqueur d'événement ingérable

Info

Publication number
MA44779A
MA44779A MA044779A MA44779A MA44779A MA 44779 A MA44779 A MA 44779A MA 044779 A MA044779 A MA 044779A MA 44779 A MA44779 A MA 44779A MA 44779 A MA44779 A MA 44779A
Authority
MA
Morocco
Prior art keywords
ingerable
compositions
pharmaceutical product
product including
event marker
Prior art date
Application number
MA044779A
Other languages
English (en)
Inventor
Markus Christen
Benedict Costello
Patricia Johnson
Nikolaus Leist
Nikhil Pargaonkar
Kurt Scheinpflug
Mark Zdeblick
Original Assignee
Otsuka Pharma Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Otsuka Pharma Co Ltd filed Critical Otsuka Pharma Co Ltd
Publication of MA44779A publication Critical patent/MA44779A/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/07—Endoradiosondes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J3/00—Devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms
    • A61J3/06—Devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms into the form of pills, lozenges or dragees
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J7/00—Devices for administering medicines orally, e.g. spoons; Pill counting devices; Arrangements for time indication or reminder for taking medicine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Inorganic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Surgery (AREA)
  • Molecular Biology (AREA)
  • Medical Informatics (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pathology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Psychiatry (AREA)
  • Neurology (AREA)
  • Organic Chemistry (AREA)
  • Neurosurgery (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
MA044779A 2016-04-25 2017-04-25 Compositions de produit pharmaceutique comprenant un marqueur d'événement ingérable MA44779A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201662327418P 2016-04-25 2016-04-25

Publications (1)

Publication Number Publication Date
MA44779A true MA44779A (fr) 2019-03-06

Family

ID=60159658

Family Applications (1)

Application Number Title Priority Date Filing Date
MA044779A MA44779A (fr) 2016-04-25 2017-04-25 Compositions de produit pharmaceutique comprenant un marqueur d'événement ingérable

Country Status (6)

Country Link
US (1) US20190167595A1 (fr)
EP (1) EP3448387A4 (fr)
JP (1) JP2019515032A (fr)
MA (1) MA44779A (fr)
TW (1) TWI730087B (fr)
WO (1) WO2017188260A1 (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA3153802A1 (fr) * 2019-10-08 2021-04-15 Mir A. Imran Dispositif d'administration de formulation a liberation controlee pour une administration a un site cible

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK1889198T3 (da) * 2005-04-28 2015-02-09 Proteus Digital Health Inc Farma-informatiksystem
UA109424C2 (uk) * 2009-12-02 2015-08-25 Фармацевтичний продукт, фармацевтична таблетка з електронним маркером і спосіб виготовлення фармацевтичної таблетки
EP2632463B1 (fr) * 2010-10-28 2018-04-04 Aequus Pharmaceuticals Inc. Compositions d'aripiprazole et méthodes pour leur administration transdermique
HUE065359T2 (hu) * 2011-03-18 2024-05-28 Alkermes Pharma Ireland Ltd Szorbitán-észtereket tartalmazó gyógyászati készítmények
WO2014104989A1 (fr) * 2011-12-27 2014-07-03 Mahmut Bilgic Compositions pharmaceutiques comprenant de l'aripiprazole

Also Published As

Publication number Publication date
TW201832751A (zh) 2018-09-16
JP2019515032A (ja) 2019-06-06
TWI730087B (zh) 2021-06-11
EP3448387A1 (fr) 2019-03-06
WO2017188260A1 (fr) 2017-11-02
US20190167595A1 (en) 2019-06-06
EP3448387A4 (fr) 2019-12-11

Similar Documents

Publication Publication Date Title
MA47094A (fr) Promédicaments d'ester aliphatique antiviral de ténofovir
MA47816A (fr) Composition pharmaceutique comprenant du sélexipag
MA46685A (fr) Extrait d'une composition à base de plantes médicinales en tant qu'agent antimicrobien et/ou antibiofilm
DK3935068T3 (da) Abirateron-prodrugs
MA43705A (fr) Formulation pharmaceutique
MA49116A (fr) Compositions pharmaceutiques contenant de l'insuline
MA47516A (fr) Composition pharmaceutique
MA40781A (fr) Composition pharmaceutique d'isotrétinoïne à faible dosage destinée à la voie orale
FR3027027B1 (fr) Produit renforce comprenant une composition comprenant un systeme oxyde metallique et derive d'acide stearique equilibre et pneumatique comprenant ledit produit renforce
FR3039378B1 (fr) Ensemble de conditionnement d'un produit cosmetique
MA45158A (fr) Composition pharmaceutique comprenant de l'éteplirsen
MA42964A (fr) Préparation pharmaceutique anti-vieillissement
MA49947A (fr) Compositions pharmaceutiques contenant des anticorps anti-bêta-amyloïdes
IL274893A (en) Pharmaceutical formulation of 3 alpha-ethenyl-3 beta-hydroxyandrostan-17-one oxime
MA44079A (fr) Compositions pharmaceutiques comprenant un dérivé de phénylaminopyrimidine
MA52704A (fr) Préparation pharmaceutique
IL268344A (en) A system for use in a pharmaceutical product
MA45794A (fr) Système de marqueur pour confirmer l'exactitude de compositions et de formulations agrochimiques
MA44779A (fr) Compositions de produit pharmaceutique comprenant un marqueur d'événement ingérable
MA45126A (fr) Formulation pharmaceutique antifongique
MA52587A (fr) Composés d'azabenzimidazole et produit pharmaceutique
MA45457A (fr) Médicament ophtalmique contenant du salbutamol.
DK3453390T3 (da) Farmaceutisk sammensætning indeholdende polymeriseret lægemiddel
MA46642A (fr) Promédicaments d'inhibiteurs de la kallicréine
FR3027602B1 (fr) Procede de synthese d'un polymere porteur de groupement hydroxyaryle, produit issu de ce procede et composition le contenant